Department of Hematology, Chinese PLA General Hospital, 28 Fuxing Road, Beijing 100853, China.
Ann Hematol. 2012 Aug;91(8):1235-43. doi: 10.1007/s00277-012-1431-4. Epub 2012 Feb 29.
ETV6 is an important hematopoietic regulatory factor and ETV6 gene rearrangement is involved in a wide variety of hematological malignancies. In this study, we sought to investigate the incidence of ETV6-associated fusion genes in B- and T-lineage acute lymphoblastic leukemia (ALL) by multiplex-nested reverse transcription-polymerase chain reaction (RT-PCR) in 176 adult ALL patients. Total RNA was extracted from bone marrow samples of ALL patients including 136 B- and 40 T-lineage ALL, and ETV6 fusion genes were detected by multiplex-nested RT-PCR. Changes of ETV6 fusion gene mRNA transcript levels were examined by real-time RT-PCR. We detected a total of 15 ETV6 gene rearrangements with a positive rate of 8.5%, involving seven ETV6-associated fusion genes in 13 B-ALL (13/136, 9.6%) and 2 T-ALL patients (2/40, 5.0%). ETV6-RUNX1 were observed in six cases (3.4%), ETV6-JAK2 in three cases (1.7%), ETV6-ABL1 in two cases (1.1%), and ETV6-ABL2, ETV6-NCOA2, ETV6-SYK, and PAX5-ETV6 each in one case (0.6%). ETV6-JAK2 was found in both B-ALL and T-ALL patients. Furthermore, real-time quantitative RT-PCR assays showed that the ETV6-RUNX1 mRNA transcript levels decreased during conventional chemotherapy or hematopoietic stem cell transplantation. This study shows that multiplex-nested RT-PCR is an effective and accurate tool to identify ETV6 rearrangements in adult ALL, which provides some clues into the diagnosis and prognosis of ALL but also molecular markers for the detection of minimal residual disease in adult ALL.
ETV6 是一种重要的造血调节因子,ETV6 基因重排涉及多种血液恶性肿瘤。在这项研究中,我们通过多重巢式逆转录聚合酶链反应(RT-PCR)在 176 例成人急性淋巴细胞白血病(ALL)患者中检测 B 系和 T 系 ALL 中 ETV6 相关融合基因的发生率。从 ALL 患者的骨髓样本中提取总 RNA,包括 136 例 B 系和 40 例 T 系 ALL,并通过多重巢式 RT-PCR 检测 ETV6 融合基因。通过实时 RT-PCR 检测 ETV6 融合基因 mRNA 转录本水平的变化。我们共检测到 15 种 ETV6 基因重排,阳性率为 8.5%,在 13 例 B-ALL(13/136,9.6%)和 2 例 T-ALL 患者中发现 7 种 ETV6 相关融合基因(2/40,5.0%)。观察到 6 例 ETV6-RUNX1(3.4%)、3 例 ETV6-JAK2(1.7%)、2 例 ETV6-ABL1(1.1%)和 1 例 ETV6-ABL2、ETV6-NCOA2、ETV6-SYK 和 PAX5-ETV6(0.6%)。ETV6-JAK2 见于 B 系和 T 系 ALL 患者。此外,实时定量 RT-PCR 检测显示,ETV6-RUNX1 mRNA 转录本水平在常规化疗或造血干细胞移植期间降低。本研究表明,多重巢式 RT-PCR 是鉴定成人 ALL 中 ETV6 重排的有效且准确的工具,为 ALL 的诊断和预后提供了一些线索,也为成人 ALL 微小残留病的检测提供了分子标志物。